AVEO Pharmaceuticals: An Update On This ~$3 Oncology Concern

About: AVEO Pharmaceuticals, Inc. (AVEO)
by: Bret Jensen
This article is exclusive for subscribers.
Bret Jensen
Specializing in biotech stocks, Small Caps, managing optimized portfolios

Today we revisit small oncology concern AVEO Pharmaceuticals after the stock's better-than-15% move on Monday.

We look at the progress the company has made and what may lie ahead for it and its stock.

A full investment analysis on this ~$3 oncology concern is provided in the paragraphs below.

"It's probably my job to tell you life isn't fair, but I figure you already know that. So instead, I'll tell you that hope is precious, and you're right not to give up." - C.J.